0002037518-24-000003.txt : 20240918 0002037518-24-000003.hdr.sgml : 20240918 20240918150439 ACCESSION NUMBER: 0002037518-24-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240918 DATE AS OF CHANGE: 20240918 EFFECTIVENESS DATE: 20240918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amaryllis Therapeutics, Inc. CENTRAL INDEX KEY: 0002037518 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524377 FILM NUMBER: 241307171 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-3650 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0002037518 Amaryllis Therapeutics, Inc. 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-863-3650 DELAWARE None None Corporation true 2024 Jeongseuk Kang 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer Director Emmanouil Karagiannis 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 Director Other Decline to Disclose 06b false 2024-09-10 false true false 0 1500000 1500000 0 false 1 0 0 0 false Amaryllis Therapeutics, Inc. /s/ Jeongseuk Kang Jeongseuk Kang Chief Executive Officer 2024-09-18